About Conference

ME Conferences cordially invites all the participants across the globe to attend the “International Conference on Molecular Markers and Cancer Therapeutics” October 23-24, 2020 Cape Town,  the largest and most populous city in South Africa. Molecular Markers 2020 is organized around the theme: “Clinical Advancements in Discovery of Molecular Markers in Cancer Treatment”.

This gathering is a rostrum that brings and offers aggregate learning and research investigations in Molecular Markers. In the current years, the information about Cancer Therapeutics has expanded to a great extent giving a colossal potential for enhancing the administration of malignancy patients by enhancing the exactness of detection and viability of treatment. Most recent innovative progressions have empowered the examination of numerous Biomarkers and have re-established enthusiasm for developing new Molecular Markers. Every such advancement can be evidenced in this Molecular Markers 2020.

WHY TO ATTEND?

With members from around the world focused on research in Molecular Markers and Cancer Therapeutics, and its advances, it is a great opportunity to update to latest regulatory guidelines and approvals in Molecular Marker research; Experience live case studies from pioneers who developed & created a Biomarker; Best platform to promote collaborative research & initiate long-lasting business partnerships and a World-class platform to Exhibit the products and services. World-renowned speakers, the most recent techniques, developments and the newest updates in Cancer Therapeutics are hallmarks of this conference.

TARGET AUDIENCE:

Oncologists

Molecular Biologists

Cell Biologists

Pathologists

Haematologists

Immunologists

Clinical Researchers

Nursing

Cancer Researchers

Scientists

Young Researchers

Molecular Marker Associations and Societies

Cancer Therapeutics Institutes

Training Institutes

Business Entrepreneurs

Software developing companies

Manufacturing Medical Devices Companies

Data Management Companies

Pharmaceutical Companies

Diagnostics Companie